Two of the most promising treatments for obesity in recent years are semaglutide, a GLP-1 agonist, and tirzepatide, a dual GLP-1/GIP agonist. These peptides have garnered attention for their impressive efficacy in weight loss and metabolic improvement, but they differ in their mechanisms, dosing, side effects, and outcomes. In this podcast, we’ll explore how these […]
Latest Articles
Potential of GLP-1 Agonists in Alzheimer’s Disease
Alzheimer’s disease is a type of dementia characterized by memory loss, cognitive decline, and a decline in the ability to perform daily tasks (e.g., planning and organizing). It can also affect mood and personality and impair judgment and language. Research has shown that Alzheimer’s results from amyloid plaques and neurofibrillary tangles in brain tissue, which […]
Weight Loss Plateau with GLP-1 Agonists
In the journey of weight loss, everyone eventually reaches a plateau, even when using newer GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound). This phase is where the body finds a new set point and weight. During this plateau, some individuals may experience a gradual increase in appetite or “food noise”, while others can […]
Debunking the Myth: “You Can’t Stop Taking GLP-1 Agonists”
One common misconception about GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Zepbound), is that once you start taking them, you can never stop. This myth can deter individuals from considering these highly effective medications for weight loss. In this podcast, we’ll debunk this myth and provide a clearer understanding of how GLP-1 agonists can […]
Appetite Changes on GLP-1 Agonists
GLP-1 agonists, such as semaglutide (Wegovy), are popular medications for weight loss that work by mimicking the action of the GLP-1 hormone, which helps regulate appetite and blood sugar levels. While these medications can be very effective, some individuals might experience fluctuations in their appetite over time. If you’ve noticed that your appetite seems to […]
Does Semaglutide Cause NAION?
In a recent study published in JAMA Ophthalmology, researchers explored a possible link between the medication semaglutide and a rare type of eye stroke called non-arteritic anterior ischemic optic neuropathy (NAION). In this podcast, we’ll explain what this means and why it’s important. What is NAION? NAION is a condition that affects the optic nerve, […]